Pertussis and influenza vaccination among insured pregnant women — Wisconsin, 2013–2014

Morbidity and Mortality Weekly Report

Volumn 64, Issue 27, 2015, Pages 746-750

  Koepke, Ruth ^a,b   Kahn, Danielle ^a   Petit, Ashley B ^a   Schauer, Stephanie L ^a   Hopfensperger, Daniel J ^a   Conway, James H ^b   Davis, Jeffrey P ^a  

^a Wisconsin Division of Public Health   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE;

ADOLESCENT; ADULT; CHILD; FEMALE; HEALTH INSURANCE; HUMAN; INFLUENZA, HUMAN; PREGNANCY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INSURANCE, HEALTH; PREGNANCY; VACCINATION; WHOOPING COUGH; WISCONSIN; YOUNG ADULT;

EID: 84937570691     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131-5.
2. CDC. Prevention and control of seasonal influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2004;53(No. RR-6).
3. Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis 2015;60:333-7.
4. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014;384:1521-8.
5. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1424-6.
6. Kharbanda EO, Vazquez-Benitez G, Lipkind H, et al. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites. Prev Med 2014;67:316-9.
7. Housey M, Zhang F, Miller C, et al. Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in Medicaid-Michigan, 2011-2013. MMWR Morb Mortal Wkly Rep 2014;63:839-42.
8. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013;56:539-44.
9. Goldfarb IT, Little S, Brown J, Riley LE. Use of the combined tetanus-diphtheria and pertussis vaccine during pregnancy. Am J Obstet Gynecol 2014;211:299.e1-5.
10. Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women-United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 2014;63:816-21.